Featured Research

from universities, journals, and other organizations

Trends in melanoma incidence and stage at diagnosis vary by racial and ethnic group

Date:
December 21, 2009
Source:
JAMA and Archives Journals
Summary:
White and Hispanic individuals are being diagnosed with melanoma more frequently in recent years, whereas Hispanic and black patients continue to have advanced skin cancer at diagnosis, according to a new study.

White and Hispanic individuals are being diagnosed with melanoma more frequently in recent years, whereas Hispanic and black patients continue to have advanced skin cancer at diagnosis, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals.

Nationwide, the incidence (rate of new cases diagnosed) of melanoma increased 2.4 percent per year in the last decade, according to background information in the article. "Research and public education efforts have focused on melanoma prevention in white populations because of their higher risk of developing melanoma," the authors write. "Improved secondary prevention measures with earlier detection of thin (early-stage) melanoma likely account for the improved survival among whites from 68 percent in the early 1970s to 92 percent in recent years. Such advances, however, have not occurred in other racial and ethnic groups in the United States."

Shasa Hu, M.D., of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues analyzed data extracted from the Florida Cancer Data System, a state-wide, population-based cancer incidence registry. Of 41,072 cases of melanoma diagnosed from 1990 to 2004, 39,670 were diagnosed in white non-Hispanic individuals, 1,148 in white Hispanics and 254 in blacks.

In the timeframe studied, incidence rates increased by 3 percent per year among white non-Hispanic men and 3.6 percent per year among white non-Hispanic women, increased 3.4 percent among white Hispanic women and 0.9 percent among white Hispanic men, and remained relatively stable among black men and women.

However, both white Hispanics and black individuals had more advanced melanoma when they were diagnosed. Eighteen percent of white Hispanic patients and 26 percent of black patients had disease that had spread either regionally or to distant parts of their bodies, compared with 12 percent of white non-Hispanic patients. The proportion of distant-stage disease diagnosed among white Hispanic and black patients did not change significantly from 1990 to 2004, compared with a steady decrease in such advanced cases among white non-Hispanic patients.

"Melanoma among darker-skinned populations has received little attention, partly reflecting their overall lower risk compared with white non-Hispanics," the authors write. "The lowest survival rates and delayed melanoma diagnosis is often seen in blacks. With the readily expanding population and increasing melanoma rate of 2.9 percent per year, melanoma among Hispanics also becomes an increasingly important public health issue."

The improvement in melanoma diagnosis among whites is encouraging, suggesting that public education and health care provider efforts can help reduce the impact of the disease. "The results of our study should motivate the expansion of melanoma awareness and screening campaigns to the minority communities, which can ultimately alleviate the disparities in melanoma outcome in these populations," the authors conclude.

Editorial: Targeted Efforts Needed to Improve Disparities

"This study adds to a growing body of literature that identifies a pervasive and persistent disparity in the stage of melanoma diagnosis between Hispanic and black patients vs. white patients," write Claudia Hernandez, M.D., of the University of Illinois at Chicago, and Robin J. Mermelstein, Ph.D., in an accompanying editorial.

"It is likely that no single risk factor will be responsible for this growing problem," they continue. "As our specialty moves forward, it is of vital importance that we not relegate our efforts exclusively to surveillance and database reviews but move quickly in an attempt to intervene. An effective education and outreach model that transcends cultural and language barriers must be formulated."

"This article offers suggestions for a number of potential points of investigation and intervention," they conclude. "It is important for physicians, researchers and the general public to realize that disparities are not inevitable. All population groups deserve equal access, equal care and an equal opportunity to enjoy good health."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal References:

  1. Shasa Hu; Yisrael Parmet; Glenn Allen; Dorothy F. Parker; Fangchao Ma; Panta Rouhani; Robert S. Kirsner. Disparity in Melanoma: A Trend Analysis of Melanoma Incidence and Stage at Diagnosis Among Whites, Hispanics, and Blacks in Florida. Arch Dermatol, 2009; 145 (12): 1369-1374 [link]
  2. Claudia Hernandez; Robin J. Mermelstein. A Conceptual Framework for Advancing Melanoma Health Disparities Research. Arch Dermatol, 2009; 145 (12): 1442-1446 [link]

Cite This Page:

JAMA and Archives Journals. "Trends in melanoma incidence and stage at diagnosis vary by racial and ethnic group." ScienceDaily. ScienceDaily, 21 December 2009. <www.sciencedaily.com/releases/2009/12/091221212748.htm>.
JAMA and Archives Journals. (2009, December 21). Trends in melanoma incidence and stage at diagnosis vary by racial and ethnic group. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2009/12/091221212748.htm
JAMA and Archives Journals. "Trends in melanoma incidence and stage at diagnosis vary by racial and ethnic group." ScienceDaily. www.sciencedaily.com/releases/2009/12/091221212748.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins